ONCOLOGY

9 Carcinoid and Neuroendocrine Tumors: Intra-arterial Therapies

Jun 7, 2020 by in ONCOLOGY Comments Off on 9 Carcinoid and Neuroendocrine Tumors: Intra-arterial Therapies

10.1055/b-0035-129539 9 Carcinoid and Neuroendocrine Tumors: Intra-arterial TherapiesElena N. Petre, Karen Brown, and Constantinos Sofocleous 9.1 Introduction Neuroendocrine tumors (NETs) are rare, typically slow-growing tumors that are frequently found only…

read more

7 Colorectal Hepatic Metastatic Disease: Ablation

Jun 7, 2020 by in ONCOLOGY Comments Off on 7 Colorectal Hepatic Metastatic Disease: Ablation

10.1055/b-0035-129537 7 Colorectal Hepatic Metastatic Disease: AblationMuneeb Ahmed 7.1 Introduction Percutaneous image-guided tumor ablation can be used to effectively treat hepatic metastases from primary colorectal cancer. Specific advantages of percutaneous…

read more

10 Cholangiocarcinoma: Ablation and Intra-arterial Therapies

Jun 7, 2020 by in ONCOLOGY Comments Off on 10 Cholangiocarcinoma: Ablation and Intra-arterial Therapies

10.1055/b-0035-129540 10 Cholangiocarcinoma: Ablation and Intra-arterial TherapiesMatthew Brown, Paul J. Rochon, Rajan K. Gupta, and Charles E. Ray, Jr. 10.1 Introduction Cholangiocarcinoma is an aggressive neoplasm originating from the bile…

read more

5 Hepatocellular Carcinoma: Chemoembolization

Jun 7, 2020 by in ONCOLOGY Comments Off on 5 Hepatocellular Carcinoma: Chemoembolization

10.1055/b-0035-129535 5 Hepatocellular Carcinoma: ChemoembolizationSiddharth A. Padia and Matthew J. Kogut 5.1 Introduction Patients with hepatocellular carcinoma (HCC) frequently present in later stages when curative treatments are no longer an…

read more

2 Adrenal Malignancy: Ablation

Jun 7, 2020 by in ONCOLOGY Comments Off on 2 Adrenal Malignancy: Ablation

10.1055/b-0035-129532 2 Adrenal Malignancy: AblationAradhana M. Venkatesan and Bradford J. Wood 2.1 Introduction Adrenal masses are a common clinical challenge, and incidental adrenal lesions may be detected on imaging in…

read more

1 Percutaneous Ablation of Renal Cell Carcinoma

Jun 7, 2020 by in ONCOLOGY Comments Off on 1 Percutaneous Ablation of Renal Cell Carcinoma

10.1055/b-0035-129531 1 Percutaneous Ablation of Renal Cell CarcinomaShawn Ahmed, Raul N. Uppot, and Debra A. Gervais 1.1 Introduction Renal cell carcinoma (RCC) accounts for approximately 4% of all adult malignancies,…

read more

5 Chemotherapeutic Agents

May 21, 2020 by in ONCOLOGY Comments Off on 5 Chemotherapeutic Agents

10.1055/b-0038-160296 5 Chemotherapeutic AgentsDouglas M. Coldwell Abraxane, see Paclitaxel Adriamycin, see Doxorubicin Allopurinol Type: Antihyperuricemic agent. Method of action: Xanthine oxidase inhibitor. Half-life: 2 hours. Metabolized: Liver. Excretion: Feces. Indications:…

read more

19 Building an Interventional Oncology Practice

May 21, 2020 by in ONCOLOGY Comments Off on 19 Building an Interventional Oncology Practice

10.1055/b-0038-160310 19 Building an Interventional Oncology PracticeDouglas M. Coldwell Like much in medicine, new practices and procedures must have adequate clinical studies for background, an unmet need to be filled,…

read more
Premium Wordpress Themes by UFO Themes